Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine
Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges
| Overview / Abstract: |
The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging standards (ie, the R-ISS), imaging techniques, and maintenance therapy options added in the last 12 years. To help hematologist-oncologists keep pace with these advancements and to illustrate their optimal use in practice, this Virtual Practice reviews two multiple myeloma patient cases and invites learners to help determine the best strategies for their care. Also featured is the Resource Library, which houses materials that will be useful to your practice. |
|
Expiration |
Jun 08, 2018 |
|
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine, RedMedEd, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
A. Keith Stewart, MBChB, MRCP, FRCPC, MBA—Program Chair Faith E. Davies, MBBCh, MRCP, MD, FRCPath Thierry Facon, MD |
|
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Hematology, Education / Teaching |
|
Sponsors / Supporters / Grant Providers |
Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology. |
|
Keywords / Search Terms |
RedMedEd RedMedEd RedMedEd, MMRF, MM, multiple myeloma, relapsed/refractory MM, CNE, Free CNE, oncology nurses Free CE CME Live CE CME Free CE CME |
|